Leadership Overview
OPKO Health has 5 executives leading key functions including strategy, finance, operations, marketing, and renal services.
Driven by innovation, OPKO Health is dedicated to advancing healthcare through integrated pharmaceutical and diagnostic solutions, impacting serious diseases globally.
Driven by innovation, OPKO Health is dedicated to advancing healthcare through integrated pharmaceutical and diagnostic solutions, impacting serious diseases globally.
Leadership Roles at OPKO Health
Phillip Frost - Chief Executive Officer & Chairman
Phillip Frost, the Chief Executive Officer & Chairman at OPKO Health, directs the overarching corporate strategy and governance. Frost guides the company's expansion in both its pharmaceutical and diagnostic segments, ensuring alignment with the mission to discover, develop, and commercialize medicines and diagnostic testing services for serious diseases. This leadership role involves setting the strategic vision for the company's operations across the United States and internationally, including its established pharmaceutical platforms in multiple countries. Phillip Frost oversees the advancement of multispecific antibody therapies for oncology and infectious disease through its biotechnology subsidiary, driving innovation in critical therapeutic areas. The Chairman's focus extends to fostering strategic partnerships and ensuring the company's long-term growth and market impact on the NASDAQ.
Charles Bishop - Chief Executive Officer, OPKO Renal
Charles Bishop, the Chief Executive Officer, OPKO Renal at OPKO Health, spearheads the strategic direction and operational execution for the company's renal division. Bishop focuses on advancing treatments and diagnostic services specifically tailored for kidney-related diseases, aligning with OPKO Health's broader mission in serious disease management. This leadership position involves overseeing the development and commercialization of innovative solutions within the renal therapeutic area. Charles Bishop drives the growth and market presence of OPKO Renal, ensuring its contributions to the company's integrated healthcare model. The Chief Executive Officer's efforts are vital for expanding the reach and impact of specialized renal care services.
Alfredo Kaffie - Chief Financial Officer
Alfredo Kaffie, the Chief Financial Officer at OPKO Health, manages the company's financial operations and fiscal strategy. Kaffie oversees all aspects of financial planning, reporting, and capital allocation, ensuring the financial health of the organization as it pursues its dual focus on pharmaceuticals and diagnostics. This role is critical in supporting the commercialization of new medicines and the broad range of testing services offered by the company's diagnostics segment. Alfredo Kaffie works to optimize financial performance across OPKO Health's domestic and international operations, including its pharmaceutical platforms. The Chief Financial Officer's responsibilities include managing investor relations and ensuring compliance with financial regulations, thereby supporting the company's trading on the NASDAQ.
Adam Logal - Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer
Adam Logal, the Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer at OPKO Health, executes comprehensive financial management and accounting oversight. Logal directs the company's accounting practices, treasury functions, and financial reporting, ensuring accuracy and compliance across all segments, including pharmaceuticals and diagnostics. This multifaceted role supports the strategic development and commercialization efforts for new treatments and diagnostic testing services. Adam Logal manages the company's financial resources and treasury operations, facilitating OPKO Health's expansion across the United States and internationally. The Senior Vice President's oversight is crucial for maintaining financial integrity and supporting the company's market activities, including its NASDAQ listing.
Anhar Hussain - Chief Marketing Officer & Manager, US Marketing
Anhar Hussain, the Chief Marketing Officer & Manager, US Marketing at OPKO Health, directs the strategic marketing initiatives and brand development across the United States. Hussain oversees the promotion of OPKO Health's pharmaceutical products and diagnostic testing services, ensuring effective market penetration and communication of the company's value proposition. This role is pivotal in driving commercial success for treatments in endocrinology and other therapeutic areas, as well as for the comprehensive testing services offered by the diagnostics segment. Anhar Hussain leads the US marketing teams, focusing on strategies that enhance patient access and physician engagement. The Chief Marketing Officer's expertise is critical for expanding market share and reinforcing OPKO Health's position in the healthcare industry.
Explore Leadership Teams in Manufacturing
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership MR
BG
BK
JS
Founded in 1885, Boehringer Ingelheim is a pharmaceutical company which concentrates on the development of human pharmaceuticals, biopharmaceuticals, chemicals, and animal health products.
Company Leadership EM
RP
YL
Tilray was established in 2018 in British Columbia, Canada. They specialize in the research, cultivation, production and distribution of medical cannabis and cannabinoids.
Company Leadership AF
SS
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Frequently Asked Questions Regarding OPKO Health Top Executives and Leadership Team
